China Pharma Holdings, Inc. (CPHI)
NYSEAMERICAN: CPHI · Real-Time Price · USD
0.564
-0.024 (-4.13%)
Apr 28, 2026, 4:00 PM EDT - Market closed
China Pharma Holdings Cash Flow Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2016 |
| Net Income | -3.19 | -4.74 | -3.08 | -3.97 | -3.4 | Upgrade
|
| Depreciation & Amortization | 1.58 | 2.68 | 2.75 | 2.7 | 3.09 | Upgrade
|
| Other Amortization | - | - | - | - | 0.25 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | - | 0.05 | - | - | Upgrade
|
| Stock-Based Compensation | - | - | - | 0.08 | 0.02 | Upgrade
|
| Provision & Write-off of Bad Debts | -13.67 | 0.01 | -0.02 | -0.09 | -0.26 | Upgrade
|
| Other Operating Activities | 0.55 | 0.45 | -0.01 | - | - | Upgrade
|
| Change in Accounts Receivable | 13.21 | -0.2 | -0.94 | -0.17 | -0.55 | Upgrade
|
| Change in Inventory | 0.6 | 1.59 | 0.42 | 0.23 | 1.01 | Upgrade
|
| Change in Accounts Payable | 0.65 | -0.73 | 0.31 | -0.19 | -0.33 | Upgrade
|
| Change in Unearned Revenue | -0.05 | 0.07 | -0.42 | 0.34 | -0.52 | Upgrade
|
| Change in Other Net Operating Assets | 0.47 | 0.46 | 0.23 | 0.67 | 0.44 | Upgrade
|
| Operating Cash Flow | 0.15 | -0.41 | -0.7 | -0.41 | -0.25 | Upgrade
|
| Capital Expenditures | -0.06 | -0.04 | -0.01 | -0.4 | -0.44 | Upgrade
|
| Sale (Purchase) of Intangibles | -0.08 | -0.25 | - | - | - | Upgrade
|
| Investing Cash Flow | -0.14 | -0.29 | -0.01 | -0.4 | -0.44 | Upgrade
|
| Short-Term Debt Issued | 0.26 | 0.03 | 0.03 | 0.03 | 1.18 | Upgrade
|
| Long-Term Debt Issued | 0.7 | 0.49 | 1.53 | 0.56 | 8.83 | Upgrade
|
| Total Debt Issued | 0.96 | 0.52 | 1.56 | 0.59 | 10.01 | Upgrade
|
| Short-Term Debt Repaid | - | - | - | -0.22 | -0.56 | Upgrade
|
| Long-Term Debt Repaid | -1.26 | -0.55 | -1.49 | -2.14 | -4.85 | Upgrade
|
| Total Debt Repaid | -1.26 | -0.55 | -1.49 | -2.36 | -5.41 | Upgrade
|
| Net Debt Issued (Repaid) | -0.29 | -0.03 | 0.07 | -1.77 | 4.6 | Upgrade
|
| Financing Cash Flow | -0.29 | -0.03 | 0.07 | -1.77 | 4.6 | Upgrade
|
| Foreign Exchange Rate Adjustments | 0 | -0.07 | 0.03 | -0.25 | -0.01 | Upgrade
|
| Net Cash Flow | -0.28 | -0.8 | -0.61 | -2.83 | 3.9 | Upgrade
|
| Free Cash Flow | 0.09 | -0.44 | -0.71 | -0.81 | -0.69 | Upgrade
|
| Free Cash Flow Margin | 2.15% | -9.81% | -10.14% | -10.01% | -7.13% | Upgrade
|
| Free Cash Flow Per Share | 0.02 | -0.26 | -2.10 | -7.72 | -7.46 | Upgrade
|
| Cash Interest Paid | 0.07 | 0.09 | 0.09 | 0.14 | 0.22 | Upgrade
|
| Levered Free Cash Flow | 1.05 | 0.38 | -0.17 | 0.85 | -0.64 | Upgrade
|
| Unlevered Free Cash Flow | 1.12 | 0.47 | 0.04 | 1.12 | -0.55 | Upgrade
|
| Change in Working Capital | 14.87 | 1.19 | -0.4 | 0.88 | 0.05 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.